FrancophonIA/ELRC3.0 huggingface dataset:
English: Pregabalin Mylan 200 mg hard capsules EU/1/15/997/035
Croatian: Pregabalin Mylan 200 mg tvrde kapsule EU/1/15/997/035
English: Pregabalin Mylan 200 mg hard capsule
Croatian: Pregabalin Mylan 200 mg tvrde kapsule
English: Pregabalin Mylan 300 mg hard capsules EU/1/15/997/045
Croatian: Pregabalin Mylan 300 mg tvrde kapsule EU/1/15/997/045
English: Erectile dysfunction Sexual dysfunction, ejaculation delayed, dysmenorrhoea, breast pain Amenorrhoea, breast discharge, breast enlargement, gynaecomastia
Croatian: Rijetko amenoreja, iscjedak iz dojke, povećanje dojki, ginekomastija
English: Pregabalin Mylan 225 mg hard capsules EU/1/15/997/040
Croatian: Pregabalin Mylan 225 mg tvrde kapsule EU/1/15/997/040
English: Pregabalin Mylan 225 mg hard capsule
Croatian: Pregabalin Mylan 225 mg tvrde kapsule
English: Pregabalin Mylan 75 mg hard capsule
Croatian: Pregabalin Mylan 75 mg tvrde kapsule
English: Pregabalin Mylan 50 mg hard capsules Each hard capsule contains 50 mg of pregabalin.
Croatian: Pregabalin Mylan 50 mg tvrde kapsule Svaka tvrda kapsula sadrži 50 mg pregabalina.
English: Pregabalin Mylan 100 mg hard capsule
Croatian: Pregabalin Mylan 100 mg tvrde kapsule
English: INFORMATION IN BRAILLE Pregabalin Mylan 100 mg
Croatian: 16. PODACI NA BRAILLEOVOM PISMU Pregabalin Mylan 100 mg
English: INFORMATION IN BRAILLE Pregabalin Mylan 300 mg
Croatian: 16. PODACI NA BRAILLEOVOM PISMU Pregabalin Mylan 300 mg
English: Pregabalin Mylan 150 mg hard capsule
Croatian: Pregabalin Mylan 150 mg tvrde kapsule
English: Pregabalin Mylan 300 mg hard capsule
Croatian: Pregabalin Mylan 300 mg tvrde kapsule
English: Pregabalin Mylan 150 mg hard capsules EU/1/15/997/028
Croatian: Pregabalin Mylan 150 mg tvrde kapsule EU/1/15/997/028
English: Pregabalin Mylan 50 mg hard capsule
Croatian: Pregabalin Mylan 50 mg tvrde kapsule
English: INFORMATION IN BRAILLE Pregabalin Mylan 50 mg
Croatian: 16. PODACI NA BRAILLEOVOM PISMU Pregabalin Mylan 50 mg
English: INFORMATION IN BRAILLE Pregabalin Mylan 25 mg
Croatian: 16. PODACI NA BRAILLEOVOM PISMU Pregabalin Mylan 25 mg
English: Cardiac disorders Uncommon
Croatian: Često erektilna disfunkcija
English: Pregabalin Mylan 50 mg hard capsules EU/1/15/997/009
Croatian: Pregabalin Mylan 50 mg tvrde kapsule EU/1/15/997/009
English: NAME OF THE MEDICINAL PRODUCT Pregabalin Mylan 200 mg hard capsules pregabalin
Croatian: Pregabalin Mylan 200 mg tvrde kapsule pregabalin
English: Pregabalin Mylan 25 mg hard capsule
Croatian: Pregabalin Mylan 25 mg tvrde kapsule
English: Pregabalin Mylan 25 mg hard capsules EU/1/15/997/001
Croatian: Pregabalin Mylan 25 mg tvrde kapsule EU/1/15/997/001
English: PVC/PVDC-Al perforated unit dose blister pack containing 56 x 1 and 100 x 1 hard capsules.
Croatian: PVC/PVDC-Al perforirana blister pakiranja djeljiva na jedinične doze koja sadrže 56 x 1 i 100 x 1 tvrdu kapsulu.
English: NAME OF THE MEDICINAL PRODUCT Pregabalin Mylan 100 mg hard capsules pregabalin
Croatian: Pregabalin Mylan 100 mg tvrde kapsule pregabalin
English: No. 2, light peach opaque cap and white opaque body, hard-shell gelatin capsule filled with white to off-white powder.
Croatian: Tvrda želatinozna kapsula br. 2 sa svjetloružičastom neprozirnom kapicom i bijelim neprozirnim tijelom napunjena bjeličastim prahom.
English: The capsule is axially printed with MYLAN over PB300 in black ink on cap and body.
Croatian: Na kapsuli je poprečno otisnuto MYLAN iznad PB300 crnom tintom na kapici i tijelu.
English: NAME OF THE MEDICINAL PRODUCT Pregabalin Mylan 50 mg hard capsules pregabalin
Croatian: Pregabalin Mylan 50 mg tvrde kapsule pregabalin
English: No. 0, light peach opaque cap and white opaque body, hard-shell gelatin capsule filled with white to off-white powder.
Croatian: Tvrda želatinozna kapsula br. 0 sa svjetloružičastom neprozirnom kapicom i bijelim neprozirnim tijelom napunjena bjeličastim prahom.
English: Light peach opaque cap and light peach opaque body, hard-shell gelatin capsule filled with white to off-white powder.
Croatian: Želatinozna kapsula sa svjetloružičastom neprozirnom kapicom i svjetloružičastim neprozirnim tijelom napunjena bjeličastim prahom.
English: NAME OF THE MEDICINAL PRODUCT Pregabalin Mylan 25 mg hard capsules pregabalin
Croatian: Pregabalin Mylan 25 mg tvrde kapsule pregabalin
English: No. 3, dark peach opaque cap and dark peach opaque body, hard-shell gelatin capsule filled with white to off-white powder.
Croatian: Tvrda želatinozna kapsula br. 3 s tamnoružičastom neprozirnom kapicom i bijelim neprozirnim tijelom napunjena bjeličastim prahom.
English: Pregabalin Mylan 25 mg hard capsules Each hard capsule contains 25 mg of pregabalin.
Croatian: KVALITATIVNI I KVANTITATIVNI SASTAV Pregabalin Mylan 25 mg tvrde kapsule Svaka tvrda kapsula sadrži 25 mg pregabalina.
English: NAME OF THE MEDICINAL PRODUCT Pregabalin Mylan 225 mg hard capsules pregabalin
Croatian: Pregabalin Mylan 225 mg tvrde kapsule Pregabalin
English: NAME OF THE MEDICINAL PRODUCT Pregabalin Mylan 300 mg hard capsules pregabalin
Croatian: Pregabalin Mylan 300 mg tvrde kapsule pregabalin
English: No. 1, light peach opaque cap and light peach opaque body, hard-shell gelatin capsule filled with white to off-white powder.
Croatian: Tvrda želatinozna kapsula br. 1 sa svjetloružičastom neprozirnom kapicom i svjetloružičastim neprozirnim tijelom napunjena bjeličastim prahom.
English: NAME OF THE MEDICINAL PRODUCT Pregabalin Mylan 150 mg hard capsules pregabalin
Croatian: Pregabalin Mylan 150 mg tvrde kapsule pregabalin
English: Light peach opaque cap and white opaque body, hard-shell gelatin capsule filled with white to off-white powder.
Croatian: Želatinozna kapsula tvrde boje sa svjetloružičastom neprozirnom kapicom i bijelim neprozirnim tijelom napunjena bjeličastim prahom.
English: NAME OF THE MEDICINAL PRODUCT Pregabalin Mylan 75 mg hard capsules pregabalin
Croatian: Pregabalin Mylan 75 mg tvrde kapsule pregabalin
English: Pregabalin Mylan 75 mg hard capsules No. 4, light peach opaque cap and light peach opaque body, hard-shell gelatin capsule filled with white to off-white powder.
Croatian: Tvrda želatinozna kapsula br. 4 sa svjetloružičastom neprozirnom kapicom i svjetloružičastim neprozirnim tijelom napunjena bjeličastim prahom.
English: In most of these (15 out of 24), the response was complete.
Croatian: U većini ovih slučajeva (15 od 24), odgovor je bio potpun.
English: Vfend has also been studied in 285 children.
Croatian: Vfend se također ispitivao u 285 djece.
English: Vfend is given twice a day at least one hour before or one hour after a meal.
Croatian: Vfend se primjenjuje dva puta na dan najmanje jedan sat prije ili jedan sat nakon obroka.
English: ‘Refractory' means that the infections were not responding to treatment.
Croatian: „Refraktorno“ znači da infekcije ne reagiraju na liječenje.
English: The tablets and suspension are to be taken at least one hour before or after a meal.
Croatian: Tablete i suspenzija se moraju uzimati najmanje jedan sat prije ili nakon obroka.
English: Vfend must not be used in patients who are taking any of the following medicines:
Croatian: Vfend se ne smije koristiti u bolesnika koji uzimaju bilo koji od sljedećih lijekova:
English: Treatment duration should be as short as possible.
Croatian: Trajanje liječenja treba biti što je kraće moguće.
English: The aim of the loading dose is to reach stable blood levels.
Croatian: Cilj doze punjenja je postizanje stabilnih razina u krvi.
English: The full EPAR for Vfend can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
Croatian: Cjelovito Europsko javno izvješće o ocjeni dokumentacije o lijeku (EPAR) za lijek Vfend nalazi se na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
English: The main measure of effectiveness in all these studies was the number of patients who had a complete or partial response to treatment.
Croatian: Glavna mjera djelotvornosti u ovim ispitivanjima bio je broj bolesnika koji su imali potpuni ili djelomičan odgovor na liječenje.
English: What measures are being taken to ensure the safe and effective use of Vfend?
Croatian: Koje se mjere poduzimaju kako bi se osigurala sigurna i učinkovita primjena lijeka Vfend?
English: Caution is also needed when Vfend is taken at the same time as other medicines.
Croatian: Oprez je također potreban prilikom uzimanja lijeka Vfend istovremeno s drugim lijekovima.
English: • ritonavir (used to treat HIV infection) at doses of 400 mg or more twice a day;
Croatian: • ritonavir (koristi se za liječenje infekcije HIV-om) u dozama od 400 mg ili više dva puta na dan;
English: Treatment beyond 180 days requires careful assessment to ensure that the benefits continue to outweigh the risk for the patient.
Croatian: Liječenje dulje od 180 dana zahtjeva pažljivu procjenu kako bi se osiguralo da koristi i dalje nadmašuju rizike prisutne u bolesnika.
English: The European Commission granted a marketing authorisation valid throughout the European Union for Vfend on 19 March 2002.
Croatian: Europska komisija izdala je odobrenje za stavljanje u promet koje je za lijek Vfend na snazi u Europskoj uniji od 19. ožujka 2002.
English: Vfend is used for the treatment of adults and children over the age of two years who have the following fungal infections:
Croatian: Vfend se koristi za liječenje odraslih osoba i djece u dobi od dvije godine koji su imali sljedeće gljivične infekcije:
English: It is available as tablets (50 mg or 200 mg), as an oral suspension (40 mg/ml) and as a powder to be made up into a solution for infusion (drip into a vein).
Croatian: Dostupan je kao tablete (50mg ili 200 mg), kao oralna suspenzija (40 mg/ml), te kao prašak za pripremu otopine za infuziju (drip u venu).
English: Other information about Vfend
Croatian: Ostale informacije o lijeku Vfend
English: In the treatment of scedosporiosis and fusariosis, 28 out of 59 patients had a complete or partial response to treatment.
Croatian: U slučaju liječenja scedosporioze i fusarioze, 28 od 59 bolesnika imalo je potpuni ili djelomičan odgovor na liječenje.
English: The most common side effects with Vfend (seen in more than 1 patient in 10) are peripheral oedema (swelling of the arms and legs), headache, visual disturbances (including blurred vision, changes in colour perception and excessive sensitivity to light), respiratory distress (difficulty breathing), abdominal pain (stomach ache), nausea (feeling sick), vomiting, diarrhoea, rash and pyrexia (fever) and abnormal liver function test results.
Croatian: Najčešće nuspojave lijeka Vfend (kod više od 1 na 10 bolesnika) bile su periferni edem (oticanje ruku i nogu), glavobolja, poremećaji vida (uključujući zamućeni vid, promjene u percepciji boja i prekomjerna osjetljivost na svjetlo), respiratorni distres (otežano disanje), abdominalna bol (bol u želucu), mučnina (osjećaj slabosti), povraćanje, proljev, osip i pireksija (groznica) te abnormalni rezultati testa funkcije jetre.
English: Without a functional cell membrane, the fungus is killed or prevented from spreading.
Croatian: Bez funkcionalne stanične membrane, gljivica je ubijena ili je spriječeno njezino širenje.
English: Most patients receiving Vfend treatment for these rare infections did not tolerate or did not respond to prior treatment with other antifungal medicines.
Croatian: Većina bolesnika koja je primila liječenje lijekom Vfend za ove rijetke infekcije nije podnosila ili nije odgovarala na prethodno liječenje drugim antifungicidima.
English: In adults, both the loading and the maintenance doses can be given by infusion or by mouth using either the tablets or the suspension, but in children it is recommended to start treatment with the infusion and to consider switching to the suspension if an improvement is seen.
Croatian: U odraslih osoba se doza punjenja i doza održavanja mogu primjeniti infuzijom ili peroralnom primjenom tablete ili suspenzije, no u djece se preporuča početak liječenja infuzijom te je potrebno razmisliti o prelasku na suspenziju ako se uoči poboljšanje.
English: Preventive treatment should last for as short a time as possible.
Croatian: Preventivno liječenje mora trajati što je kraće moguće.
English: It works by disrupting the formation of ergosterol, which is an important component of fungal cell membranes.
Croatian: Djeluje rastvarajući formaciju ergosterola, koji je važna komponenta stanične membrane gljivice.
English: The study of Vfend in the treatment of invasive aspergillosis involved 277 immunocompromised patients (patients whose immune system was not working properly).
Croatian: Ispitivanje lijeka Vfend u liječenju invanzive aspergiloze obuhvatilo je 277 imunokompromitiranih bolesnika (bolesnici čiji imunosni sustav nije ispravno funkcionirao).
English: What is Vfend?
Croatian: Što je Vfend?
English: Treatment was considered to be successful if a patient was able to continue treatment for 100 days after the transplantation and had not developed a fungal infection by day 180.
Croatian: Liječenje se smatralo uspješnim ako je bolesnik mogao nastaviti liječenje tijekom 100 dana nakon translplantacije i nije razvio gljivičnu infekciju do 180. dana.
English: A successful outcome was seen in 44% of the patients with serious refractory Candida infections (24 out of 55).
Croatian: Uspješan je ishod uočen u 44% bolesnika s ozbiljnom refraktornom infekcijom kandide (24 od 55).
English: What is the risk associated with Vfend?
Croatian: Koji su rizici povezani s lijekom Vfend?
English: A risk management plan has been developed to ensure that Vfend is used as safely as possible.
Croatian: Pripremljen je plan upravljanja rizikom kako bi se osigurala što sigurnija primjena lijeka Vfend.
English: It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for Vfend.
Croatian: Objašnjava kako je Odbor za lijekove za primjenu kod ljudi (CHMP) ocijenio lijek da bi donijelo svoje mišljenje u korist davanja odobrenja za stavljanje lijeka u promet i svoje preporuke o uvjetima za primjenu lijeka Vfend.
English: In the study on prevention in patients who had blood stem-cell transplantation, around 49% of patients who were given Vfend (109 out of 224) had a successful treatment compared with around 33% of patients who received itraconazole (80 out of 241).
Croatian: U ispitivanju o prevenciji bolesnika koji su primili transplantaciju matičnih stanica, otprilike 49% bolesnika koji su primili Vfend (109 od 224) imalo je uspješno liječenje u usporedbi s otprilike 33% bolesnika koji su primili itrakonazole (80 od 241).
English: For more information about treatment with Vfend, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.
Croatian: Više informacija o terapiji lijekom Vfend pročitajte u uputi o lijeku (također dio EPAR-a) odnosno obratite se svom liječniku ili ljekarniku.
English: EPAR summary for the public voriconazole
Croatian: EPAR, sažetak za javnost vorikonazol
English: What benefit has Vfend shown during the studies?
Croatian: Koje su koristi lijeka Vfend dokazane u ispitivanjima?
English: It may be continued for a further 80 days but only if the patient's immune system is still suppressed or if they develop graft-versus-host disease (when the transplanted cells start attacking the body's own cells).
Croatian: Može se nastaviti tijekom 80 dana, no samo ako se u bolesnika razvila imunosupresija ili reakcija presatka protiv primatelja (u slučaju kada presađene stanice počnu napadati vlastite stanice tijela).
English: • terfenadine, astemizole (commonly used for allergy - these medicines may be available without a prescription);
Croatian: • terfenadin, astemizol (često se koriste protiv alergija - ovi lijekovi mogu biti dostupni i bez recepta);
English: Vfend has also been studied in the treatment of serious refractory Candida infections in 55 patients, in scedosporiosis in 38 patients, and in fusariosis in 21 patients.
Croatian: Vfend se također ispitivao u liječenju ozbiljnih refraktornih infekcija kandidom u 55 bolesnika, skedosporioze u 38 bolesnika i fusarioze u 21 bolesnika.
English: This is a summary of the European public assessment report (EPAR) for Vfend.
Croatian: Ovo je sažetak Europskoga javnog izvješća o ocjeni dokumentacije o lijeku (EPAR) za Vfend.
English: The loading dose is then followed by a maintenance dose that can be adjusted according to the patient's response.
Croatian: Nakon doze punjenja slijedi doza održavanja koja se može prilagoditi ovisno o odgovoru bolesnika.
English: Vfend was compared with amphotericin B (another antifungal medicine).
Croatian: Vfend je uspoređen s amfotericinom B (drugim antifungicidom).
English: • candidaemia (another type of fungal infection due to Candida) in patients with a normal white blood cell count;
Croatian: • kandidemiju (drugi tip gljivične infekcije uzrokovan gljivicom Candida) u bolesnika s normalnim brojem bijelih krvnih stanica;
English: When used to treat fungal infections, patients need to receive an initial higher dose (loading dose) on the first day.
Croatian: Ako se koristi za liječenje gljivičnih infekcija, bolesnici trebaju prvoga dana primiti početnu veću dozu (doza punjenja).
English: Vfend is also used to prevent invasive fungal infections in patients who have had undergone haematopoietic (blood) stem-cell transplant (a transplant of a type of stem cells that can develop into blood cells) and are at high risk of infection.
Croatian: Vfend se također koristi za spriječavanje invanzivnih gljivičnih infekcija u bolesnika koji su se podvrgnuli transplantaciji hematopoetskih (krvnih) matičnih stanica (transplatacija tipa matičnih stanica koje se mogu razviti u krvne stanice), te su izloženi velikom riziku od infekcije.
English: Treatment should be stopped if patients experience treatment-related side effects.
Croatian: Liječenje treba prekinuti ako se u bolesnika manifestiraju nuspojave povezane s liječenjem.
English: When used for treatment of fungal infections, Vfend is intended mainly for patients with worsening and possibly life-threatening infections.
Croatian: Ako se koristi za liječenje gljivičnih infekcija, Vfend je predviđen uglavnom za bolesnike s pogoršanim i po život opasnim infekcijama.
English: In a study involving 465 patients, Vfend was compared with another antifungal medicine, itraconazole.
Croatian: U ispitivanju koje je obuhvatilo 465 bolesnika, Vfend je uspoređen s drugim antifungicidom, itrakonazolom.
English: • ergot alkaloids such as ergotamine and dihydroergotamine (used to treat migraine headache);
Croatian: • ergot alkaloidi poput ergotamina i dihidroergotamina (koji se koriste za liječenje mingrenske glavobolje);
English: Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Vfend, including the appropriate precautions to be followed by healthcare professionals and patients.
Croatian: Na temelju tog plana u sažetak opisa svojstava lijeka kao i u uputu o lijeku, za lijek Vfend nalaze se sigurnosne informacije, uključujući odgovarajuće mjere opreza kojih se zdravstveni djelatnici i bolesnici trebaju pridržavati.
English: For candidaemia, the percentage of responders to Vfend treatment at the end of therapy was the same as for the comparator (72%).
Croatian: U slučaju kandidemije, postotak bolesnika s odgovorom na liječenje lijekom Vfend u trenutku završetka terapije bio je isti kao i u slučaju komparatora (72%).
English: The survival for voriconazole was significantly greater than that for amphotericin B.
Croatian: Stopa preživljenja s vorikonazolom bila je znatno veća u odnosu na amfotericin B.
English: The study of Vfend in the treatment of candidaemia compared Vfend with a treatment of amphotericin B followed by fluconazole in 370 patients.
Croatian: Ispitivanje lijeka Vfend u liječenju kandidemije usporedilo je Vfend s liječenjem amfotericinom B nakon čega je uslijedio flukonazol u 370 bolesnika.
English: Why has Vfend been approved?
Croatian: Zašto je lijek Vfend odobren?
English: In the treatment of invasive aspergillosis, the proportion of patients responding to treatment was higher with Vfend than with amphotericin B (53% versus 31%).
Croatian: U liječenju invanzivne aspergiloze, dio bolesnika koji je reagirao na liječenje bio je veći s lijekom Vfend u odnosu na amfotericin B (53% u odnosu na 31%).
English: • invasive aspergillosis (a type of fungal infection due to Aspergillus);
Croatian: • invazivnu aspergilozu (tip gljivične infekcije prouzročen gljivicom Aspergillus);
English: What is Vfend used for?
Croatian: Za što se Vfend koristi?
English: When used to prevent infections in patients who have had blood stem-cell transplantation, Vfend is given on the day of the transplantation and for up to 100 days after.
Croatian: Ako se koriste za spriječavanje infekcije u bolesnika koji su imali transplantaciju krvnih matičnih stanica, Vfend se primjenjuje na dan transplantacije te nakon 100 dana.
English: The list of fungi against which Vfend is active can be found in the summary of product characteristics (also part of the EPAR).
Croatian: Popis gljivica protiv kojih je Vfend aktivan dostupan je u sažetku opisa svojstava lijeka (također dio EPAR-a).
English: The dose may be increased or decreased according to how the patient responds and the side effects experienced respectively.
Croatian: Doza se može povećati ili smanjiti ovisno o odgovoru bolesnika, odnosno nuspojavama koje su se manifestirale.
English: The active substance in Vfend, voriconazole, belongs to the ‘triazole' class of antifungal medicines.
Croatian: Djelatna tvar u lijeku Vfend, vorikonazol, ubraja se u klasu „triazola“ antifungicida.
English: The dose of Vfend to use depends on the weight of the patient and on which formulation of the medicine is used.
Croatian: Doza lijeka Vfend za primjenu ovisi o tjelesnoj težini bolesnika te formulacijui lijeka koju bolesnik koristi.
English: • serious fungal infections caused by Scedosporium or Fusarium (two different types of fungus).
Croatian: • teške gljivične infekcije uzrokovane vrstama iz rodova Scedosporium i Fusarium (dva različita tipa gljivica).
English: • high dose efavirenz (used to treat HIV infection).
Croatian: • velika doza efavirenza (koristi se za liječenje infekcije HIV-om).
English: How is Vfend used?
Croatian: Kako se Vfend koristi?
English: Vfend has also been studied as a preventative treatment in patients who have had blood stem-cell transplantation.
Croatian: Vfend se također ispitivao kao preventivno liječenje u bolesnika koji su podvrgnuti transplantaciji matičnih stanica.
English: • rifampicin (used to treat tuberculosis);
Croatian: • rifampicin (koristi se za liječenje tuberkuloze);
English: The CHMP decided that Vfend's benefits are greater than its risks and recommended that it be given marketing authorisation.
Croatian: Odbor za lijekove za humanu uporabu (CHMP) pri Agenciji odlučio je da koristi od lijeka Vfend nadmašuju s njim povezane rizike te je preporučio izdavanje odobrenja za stavljanje lijeka u promet.
English: • quinidine (used for irregular heart beat);
Croatian: • kinidin (koristi se za nepravilne otkucaje srca);
English: • phenobarbital (used for severe insomnia and seizures);
Croatian: • fenobarbital (koristi se za liječenje ozbiljne nesanice i napadaja);
English: • pimozide (used to treat mental illnesses);
Croatian: • pimozid (koristi se za liječenje mentalnih bolesti);
English: Vfend is an antifungal medicine that contains the active substance voriconazole.
Croatian: Vfend je antifungicid koji sadrži djelatnu tvar vorikonazol.
English: How does Vfend work?
Croatian: Kako djeluje Vfend?
English: How has Vfend been studied?
Croatian: Kako se Vfend ispitivao?
English: • serious invasive Candida infections when the fungus is resistant to fluconazole (another antifungal medicine);
Croatian: • tešku invazivnu infekciju uzrokovanu kandidom rezistentnom na flukonazol (drugi antifungicid);
English: • sirolimus (used in transplant patients);
Croatian: • sirolimus (koristi se u liječenju bolesnika podvrnutih transplataciji);